Screener
Kura Oncology KURA Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$68.33M-3.3% | -$73.33M-27.7% | -$81M-321% | -$74.12M-36.2% | -$66.12M-30.1% | ||
| $369K+64.7% | $355K+47.3% | $403K+97.5% | $164K-21.2% | $224K+10.9% | ||
| $8.21M+18.1% | $8.42M+7.3% | $11.35M+31.5% | $10.97M+31.7% | $6.95M-17.6% | ||
| -$62.55M-117% | -$85.85M-19.4% | —— | -$80.63M-85.6% | -$28.78M+32.3% | ||
| $656K-55.0% | $128K-56.2% | $2.32M+524% | $2.57M— | $1.46M+9,013% | ||
| $92.21M— | -$24.23M+76.1% | -$64.6M+32.0% | $93.97M— | —— | ||
| $1.5M+191% | $69K-51.7% | $1.14M+40.8% | $0-100% | $515K-83.1% | ||
| —— | -$110.02M+36.5% | —— | —— | —— | ||
| -$63.21M-109% | -$85.98M-19.1% | —— | -$83.19M-91.5% | -$30.24M+28.9% |
FAQ
- Where does Kura Oncology's cash flow data come from?
- Every line is extracted from Kura Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
